Opinion|Videos|July 25, 2024
Differentiating Bronchiectasis from COPD and Understanding Exacerbations
Author(s)Panagis Galiatsatos, MD
A pulmonary and critical care medicine physician discusses how bronchiectasis compares with other chronic respiratory disorders, highlighting the differing signs and symptoms.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- How is bronchiectasis different from other chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) or asthma?
- How do the exacerbations in bronchiectasis differ from those in COPD in terms of frequency, severity, and management?
Advertisement
Related to this article
Nicola Hanania, MD, discusses why delayed dupilumab initiation after an asthma exacerbation raises costs and outcomes risk.
Francesca Polverino, MD, PhD, discusses COPD biomarkers, patient susceptibility, overtreatment risk, and the future of risk stratification.
Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability
3
Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations
4
Risankizumab Outperforms Deucravacitinib in Moderate Plaque Psoriasis
5